Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
NCT02422628 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2016-12-14
Summary
Correlation of epithelial growth factor receptor mutation in blood of lung cancer patient and clinical outcome.
Conditions
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Chao-Chi Ho · National Taiwan University Hospital No. 7, Chung-Shan South Road, Taipei, Taiwan
Eligibility
- Min Age
- 20 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis
NCT02803619 ·Status: UNKNOWN
-
Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer
NCT04266691 ·Status: COMPLETED
-
Gene Mutations in Non-Small Cell Lung Cancer Cells
NCT00977509 ·Status: UNKNOWN
-
DNA Repair Genes and Outcomes in Patients With Stage III NSCLC
NCT00797238 ·Status: UNKNOWN
-
Novel Detection System for Lung Cancer Curative Effect Monitoring
NCT02666755 ·Status: UNKNOWN
-
The Feasibility of Dynamic Liquid Biopsy Monitoring During Neoadjuvant Treatment for EGFR-mutated NSCLC
NCT06287593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
NCT06247280 ·Status: ACTIVE_NOT_RECRUITING
-
A Prognosis and Predicting Genetic Study of Lung Cancer
NCT03234179 ·Status: NOT_YET_RECRUITING
-
Genotyping of Non-small Cell Lung Cancer
NCT02002117 ·Status: UNKNOWN
-
The Evaluation of Lung Cancer Patient Treated With Epidermal Growth Factor Receptor Tyrosine Kinase
NCT02755337 ·Status: UNKNOWN
-
The Role of Protein Tyrosine Kinase 7 (PTK7) in Non-small Cell Lung Cancer
NCT04018183 ·Status: COMPLETED
-
Genomic Study in Non-small Cell Lung Cancer Brain Metastasis
NCT04745715 ·Status: COMPLETED
-
Biomarkers in Tissue and Blood Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01139944 ·Status: COMPLETED
-
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407 ·Status: RECRUITING
-
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
NCT06198868 ·Status: RECRUITING
-
SHOX2_PTGER4 DNA Methlyation in Lung Cancer
NCT04321499 ·Status: COMPLETED
-
Formatting the Risk Prediction Models for Never-Smoking Lung Cancer
NCT05572944 ·Status: RECRUITING
-
Non Small Cell Lung Cancer Evaluation According to Pre-determined Drug-targeting Tumor Markers
NCT01141686 ·Status: COMPLETED
-
Clinical Sensitivity Verification Study of Circulating Tumor Cells Gene Mutation Detection From Advanced NSCLC Patients
NCT04229121 ·Status: UNKNOWN
-
Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients
NCT01257308 ·Status: UNKNOWN
-
An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma
NCT05759325 ·Status: NOT_YET_RECRUITING
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications
NCT00260871 ·Status: UNKNOWN
-
The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor
NCT00257179 ·Status: UNKNOWN
-
Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLC
NCT04922073 ·Status: UNKNOWN